JMJD1C expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.094000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.784100E-02
Normal-vs-Stage2
1.636240E-02
Normal-vs-Stage3
1.186560E-01
Normal-vs-Stage4
1.359380E-01
Stage1-vs-Stage2
4.899400E-01
Stage1-vs-Stage3
7.896400E-01
Stage1-vs-Stage4
6.379800E-01
Stage2-vs-Stage3
7.703200E-01
Stage2-vs-Stage4
9.302200E-01
Stage3-vs-Stage4
8.698400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.921900E-03
Normal-vs-AfricanAmerican
1.837360E-01
Normal-vs-Asian
1.100230E-01
Caucasian-vs-AfricanAmerican
3.582800E-01
Caucasian-vs-Asian
9.249200E-01
AfricanAmerican-vs-Asian
5.801200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.420150E-02
Normal-vs-Female
1.225930E-02
Male-vs-Female
5.666200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.235580E-01
Normal-vs-Age(41-60Yrs)
4.259700E-02
Normal-vs-Age(61-80Yrs)
8.578100E-03
Normal-vs-Age(81-100Yrs)
1.764250E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.108400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.915800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.572200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.200700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.540500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.299800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.170190E-02
Normal-vs-Daily Drinker
8.101700E-03
Normal-vs-Weekly Drinker
3.497600E-02
Normal-vs-Occasional Drinker
2.096400E-02
Normal-vs-Social Drinker
4.098400E-02
Non Drinker-vs-Daily Drinker
7.289400E-01
Non Drinker-vs-Weekly Drinker
7.462000E-01
Non Drinker-vs-Occasional Drinker
4.376800E-01
Non Drinker-vs-Social Drinker
9.526600E-01
Daily Drinker-vs-Weekly Drinker
9.640000E-01
Daily Drinker-vs-Occasional Drinker
2.745800E-01
Daily Drinker-vs-Social Drinker
7.379000E-01
Weekly Drinker-vs-Occasional Drinker
3.582400E-01
Weekly Drinker-vs-Social Drinker
7.612800E-01
Occasional Drinker-vs-Social Drinker
5.641800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.886400E-02
Normal-vs-Grade 2
1.019710E-03
Normal-vs-Grade 3
4.904400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.698840E-01
Grade 1-vs-Grade 3
5.242600E-01
Grade 1-vs-Grade 4
3.886400E-02
Grade 2-vs-Grade 3
2.948600E-01
Grade 2-vs-Grade 4
1.019710E-03
Grade 3-vs-Grade 4
4.904400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.620300E-03
Normal-vs-NonDiabetic
1.187850E-02
Diabetic-vs-NonDiabetic
3.329800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.642440E-01
Normal-vs-NoPancreatitis
1.018480E-02
Pancreatitis-vs-NoPancreatitis
2.206800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.757700E-03
Normal-vs-N1
1.803710E-02
N0-vs-N1
3.327600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.318200E-02
Normal-vs-TP53-NonMutant
2.978100E-02
TP53-Mutant-vs-TP53-NonMutant
2.488600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
